Home » Stocks » DXR

Daxor Corporation (DXR)

Stock Price: $9.70 USD 0.35 (3.74%)
Updated May 10, 2021 4:00 PM EDT - Market closed
Market Cap 39.13M
Revenue (ttm) 264,440
Net Income (ttm) n/a
Shares Out 4.03M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend $0.03
Dividend Yield 0.31%
Trading Day May 10
Last Price $9.70
Previous Close $9.35
Change ($) 0.35
Change (%) 3.74%
Day's Open 9.30
Day's Range 9.30 - 9.80
Day's Volume 11,863
52-Week Range 9.07 - 24.08

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the clinical utility of t...

1 week ago - GlobeNewsWire

NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will presen...

1 month ago - GlobeNewsWire

BREAKTHROUGH PATENT-PENDING TRACER DEVELOPED FOR BROAD USE

1 month ago - GlobeNewsWire

Revenues of Operating Division Increase by 50.4%

2 months ago - GlobeNewsWire

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center ...

3 months ago - GlobeNewsWire

Study Presented At the Society for Critical Care Medicine (SCCM) 50th Congress

3 months ago - GlobeNewsWire

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative me...

3 months ago - GlobeNewsWire

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative me...

4 months ago - GlobeNewsWire

NEW YORK, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume meas...

5 months ago - GlobeNewsWire

NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume meas...

5 months ago - GlobeNewsWire

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurem...

5 months ago - GlobeNewsWire

COVID-19 Investigation Continues at OHSU to Study Hospitalized Patients Utilizing Daxor's Blood Volume Analysis Technology

6 months ago - GlobeNewsWire

NEW YORK, NY, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume meas...

6 months ago - GlobeNewsWire

NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurem...

7 months ago - GlobeNewsWire

NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurem...

7 months ago - GlobeNewsWire

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurem...

7 months ago - GlobeNewsWire

NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measu...

7 months ago - GlobeNewsWire

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume mea...

7 months ago - GlobeNewsWire

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume mea...

8 months ago - GlobeNewsWire

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measur...

8 months ago - GlobeNewsWire

NEW YORK, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measur...

9 months ago - GlobeNewsWire

NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology operation...

9 months ago - GlobeNewsWire

Enrollment Commences Using the BVA-100 ® Diagnostic Blood Test

9 months ago - GlobeNewsWire

COVID-19 Investigation Commences at NYU Langone Health with Daxor’s Blood Volume Analysis Technology

9 months ago - GlobeNewsWire

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measur...

10 months ago - GlobeNewsWire

NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measur...

10 months ago - GlobeNewsWire

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measure...

11 months ago - GlobeNewsWire

NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measure...

11 months ago - GlobeNewsWire

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measu...

1 year ago - GlobeNewsWire

New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus

1 year ago - GlobeNewsWire

NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measu...

1 year ago - GlobeNewsWire

NEW YORK, March 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology operati...

1 year ago - GlobeNewsWire

NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology operatio...

1 year ago - GlobeNewsWire

NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measu...

1 year ago - GlobeNewsWire

NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measur...

1 year ago - GlobeNewsWire

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measur...

1 year ago - GlobeNewsWire

New Data Scheduled for Presentation on Daxor’s BVA-100®

1 year ago - GlobeNewsWire

NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measure...

1 year ago - GlobeNewsWire

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measure...

1 year ago - GlobeNewsWire

New York, N. Y., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...

1 year ago - GlobeNewsWire

NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measu...

1 year ago - GlobeNewsWire

About DXR

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hypo... [Read more...]

Industry
Asset Management
Founded
1970
Stock Exchange
NYSEAMERICAN
Ticker Symbol
DXR
Full Company Profile

Analyst Forecasts

According to one analyst, the rating for Daxor stock is "Buy" and the 12-month stock price forecast is 21.50.

Price Target
$21.50
Analyst Consensus: Buy